These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24841448)

  • 21. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ; Kaliner MA; LaForce CF; Baker JW; Kaiser HB; Amin D; Kundu S; Williams JE; Engelstaetter R; Banerji DD
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciclesonide and the treatment of asthma.
    Korenblat PE
    Expert Opin Pharmacother; 2010 Feb; 11(3):463-79. PubMed ID: 20102309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma.
    Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
    Pulm Pharmacol Ther; 2001; 14(2):141-7. PubMed ID: 11273796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
    Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R
    Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis.
    Hsu CK; Chao CM; Lai CC
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):1129-1130. PubMed ID: 35995666
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of inhaled corticosteroids: an update.
    Kelly HW
    Ann Pharmacother; 2009 Mar; 43(3):519-27. PubMed ID: 19261959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.
    Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo.
    Autio P; Karjalainen J; Risteli L; Risteli J; Kiistala U; Oikarinen A
    Am J Respir Crit Care Med; 1996 Mar; 153(3):1172-5. PubMed ID: 8630563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
    Vermeulen JH; Gyurkovits K; Rauer H; Engelstätter R
    Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciclesonide: long-term treatment of persistent asthma--no clear progress.
    Prescrire Int; 2013 Sep; 22(141):207. PubMed ID: 24171213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with ciclesonide in patients with mild persistent bronchial asthma].
    Bartosíková L; Necas J; Frána L; Bartosík T
    Ceska Slov Farm; 2007 Dec; 56(6):276-9. PubMed ID: 18257418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in inhaled corticosteroid pharmacology.
    Zitt MJ
    Allergy Asthma Proc; 2007; 28(2):114-24. PubMed ID: 17479594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments.
    Sorva R; Tähtelä R; Turpeinen M; Juntunen-Backman K; Haahtela T; Risteli L; Risteli J; Sorva A
    Acta Paediatr; 1996 Oct; 85(10):1176-80. PubMed ID: 8922079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ciclesonid--new generation of inhaled glucocorticosteroid].
    Chciałowski A; Płusa T
    Wiad Lek; 2004; 57(1-2):70-3. PubMed ID: 15181753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.
    Yeo SH; Aggarwal B; Shantakumar S; Mulgirigama A; Daley-Yates P
    Expert Rev Respir Med; 2017 Oct; 11(10):763-778. PubMed ID: 28752776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.